RItuximab Long-Term DOSE Trial in Multiple Sclerosis - RIDOSE-MS

Clinical trial NCT03979456 · UNKNOWN

Trial details

NCT number: NCT03979456
Sponsor: Karolinska Institutet
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Multiple Sclerosis, Relapsing-Remitting

Start date: 2018-07-04
Primary completion: 2024-12-20
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.